China NT Pharma Group Co. Ltd. announced that it has entered into two subscription agreements on 9 February 2026 for the issuance of convertible bonds with an aggregate principal amount of HK$65,000,000. Under the agreements, Subscriber A, a healthcare investment company from the PRC, will subscribe to bonds worth HK$50,000,000, and Subscriber B, an individual merchant, will subscribe to bonds worth HK$15,000,000. The bonds are convertible, granting bondholders rights to convert the principal and accrued interest into shares of the company. The closing date for the transaction is set for 30 June 2026, or an earlier or later date as agreed by the parties. Neither subscriber holds any shares in China NT Pharma Group as of the date of the announcement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China NT Pharma Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260210-12020018), on February 09, 2026, and is solely responsible for the information contained therein.